Regulatory Open Forum

 View Only
Reg Intel Conference 2024
Back to discussions
Expand all | Collapse all

Discribing fotostability in module 3 for drugs from human plasma (e.g. immunoglobulin)

  • 1.  Discribing fotostability in module 3 for drugs from human plasma (e.g. immunoglobulin)

    Posted 07-Apr-2021 02:01
    Hello RAC community,

    I have a question about evaluation of photostability for drugs from human plasma (e.g. immunoglobulin).
    Does biotechnological/biological products need evaluation of photostability in module 3 ?
    If not, what data should be representative or not .

    ------------------------------
    Kateryna Leshchenko
    Bila Tserkva
    Ukraine
    ------------------------------


Related Content